ORLANDO, FLORIDA / ACCESS Newswire / March 28, 2025 / RedChip Companies will air interviews with bioAffinity Technologies, Inc. (Nasdaq:BIAF) and Can-Fite BioPharma Ltd. (NYSE American:CANF) on ...
Case Demonstrates Benefit of Integrating CyPath ® Lung into Standard of Care for Patients Under Surveillance After Treatment for Previous Lung Cancer SAN ANTONIO, March 26, 2025--(BUSINESS WIRE ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) today released a study of a complex clinical case in which CyPath® Lung’s real-time assessment of the lung microenvironment identified a ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results